TI
MDCO

Turner Investments’s Medicines Co MDCO Stock Holding History

Turner Investments’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-86,240
Closed -$1.93M – 564
2014
Q3 		$1.93M Sell
86,240
-139,720
-62% -$3.55M 0.12% 256
2014
Q2 		$6.57M Buy
225,960
+178,460
+376% +$4.77M 0.29% 96
2014
Q1 		$1.35M Buy
+47,500
New +$1.57M 0.04% 408

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's MDCO Position: Q4 2014 in Review

Turner Investments sold out of Medicines Co (MDCO) in Q4 2014, closing a stake of 86,240 shares — an estimated $1.93M sold.

Turner Investments first reported a position in MDCO in Q1 2014 and held it in 3 quarters. The position peaked at $6.57M in Q2 2014. 166 funds tracked by Wall St. Rank hold MDCO as of Q4 2014.

  • Turner Investments reported no remaining Medicines Co position as of Q4 2014 after selling out during the quarter.
  • Turner Investments sold 86,240 Medicines Co shares in Q4 2014, an estimated $1.93M.
  • Turner Investments first reported a position in Medicines Co in Q1 2014 and held it in 3 quarters.
  • Turner Investments's Medicines Co position peaked at $6.57M in Q2 2014.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q4 2014.

Based on Turner Investments's 13F filing for Q4 2014, filed 12 Feb 2015.